Rennie Dual Action

Product Description

Chewable tablets. Off white, speckled circular tablet, flat on both sides with a bevelled edge. Symptomatic treatment of complaints resulting from gastro-oesophageal reflux & hyperacidity, such as regurgitation & heartburn. Ingredients Each tablet of 1743mg contains the following active substances: Alginic acid 150mg, calcium carbonate 625mg & heavy magnesium carbonate 73.50mg. Dosage The usual dose is 2 tablets to be chewed. It should preferably be taken one hour after meals & before going to bed. An additional dose of 2 tablets can also be taken in between in the case of heartburn. Do not take more than 16 tablets in any 24-hour period. Only for use by adults (over 12 years of age). Warnings Prolonged use should be avoided. If the symptoms persist or only partly disappear, further medical advice should be sought. As with other antacids, Rennie dual action tablets may mask a malignancy in the stomach. In general, caution should be exercised in patients with impaired renal function. If Rennie dual action tablets are used in such patients, plasma concentrations of calcium & magnesium should be monitored regularly. Prolonged use of high doses may result in undesirable side-effects such as hypercalcaemia, magnesaemia & the milk alkali syndrome, particularly in patients suffering from renal insufficiency. Prolonged use increases the risk of formation of renal calculi. Patients on a restricted-sodium diet should note that the product contains 14mg sodium per tablet. Diabetic patients should note that the product contains 230mg sucrose & about 520mg glucose per tablet. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.